Lily I Jiang1,2,3,4, Peter D Hino1,2,3,4, Lydia Parker1,2,3,4, Thomas J Stephens1,2,3,4, John Mccook1,2,3,4, Vincent Gotz1,2,3,4. 1. Drs. Jiang, Hino, and Stephens are with Thomas J. Stephens and Associates, Inc. in Richardson, Texas. 2. Dr. Parker is with the Parker Skin and Aesthetic Clinic in Beachwood, Ohio. 3. Mr. McCook is with Discovery Partners LLC in Frisco, Texas. 4. Mr. Gotz is with MDRejuvena, Inc. in Carlsbad, California.
Abstract
Objective: The objective of this study was to assess clinical safety and efficacy of a novel acne treatment regimen in adult women. Methods: Participants in the study included an ethnically diverse group of adult women (n=24) with mild-to-moderate acne who were treated twice daily with a topical regimen (cleanser, acne cream, and rebalancing gel) for eight weeks. Following baseline assessments, subjects returned to clinic at Weeks 2, 4, and 8 for clinical assessments and self-assessment questionnaires. Results: Twenty-one of the 24 enrolled women completed the eight-week clinical trial. Statistically significant clinical improvements were seen in both acne and aging parameters over time. The product regimen was well tolerated without adverse reactions commonly seen with topical acne products. Conclusion: The regimen demonstrated efficacy and tolerability in adult women with acne and signs of skin aging.
Objective: The objective of this study was to assess clinical safety and efficacy of a novel acne treatment regimen in adult women. Methods:Participants in the study included an ethnically diverse group of adult women (n=24) with mild-to-moderate acne who were treated twice daily with a topical regimen (cleanser, acne cream, and rebalancing gel) for eight weeks. Following baseline assessments, subjects returned to clinic at Weeks 2, 4, and 8 for clinical assessments and self-assessment questionnaires. Results: Twenty-one of the 24 enrolled women completed the eight-week clinical trial. Statistically significant clinical improvements were seen in both acne and aging parameters over time. The product regimen was well tolerated without adverse reactions commonly seen with topical acne products. Conclusion: The regimen demonstrated efficacy and tolerability in adult women with acne and signs of skin aging.